NCT06751602: Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
- State
- Under way
- Phase
- Phase 2
- People
- 40 planned
- Started
- 11 Sep 2025
- Primary completion
- Dec 2027
- Arms
- Belumosudil
- Results
- None posted
- 30 Dec 2024: Trial registered
- 11 Sep 2025: Trial started